Urinary levels, tissue concentrations and lung inflammation after nose-only exposure to three different chemical forms of beryllium

Journal of Applied Toxicology

Volumn 30, Issue 5, 2010, Pages 411-415

  Muller, Caroline ^a   Mazer, Bruce ^b   Salehi, Fariba ^b   Audusseau, Séverine ^b   Chevalier, Gaston ^c   Truchon, Ginette ^d   Larivière, Pierre ^d   Paquette, Vincent ^d   Lambert, Jean ^a   Zayed, Joseph ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^d INSTITUT DE RECHERCHE ROBERT SAUVÉ EN SANTÉ ET EN SÉCURITÉ DU TRAVAIL   (Canada)

Author keywords

Be species; Lung inflammation; Nose only exposure; Toxicity; Urine Be

Indexed keywords

BERYLLIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; HISTOLOGY; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PNEUMONIA; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TOXICOKINETICS; URINALYSIS; URINARY EXCRETION; ANIMAL; BERYLLIOSIS; C3H MOUSE; CHEMISTRY; DRUG EFFECTS; EXPOSURE; LUNG; METABOLISM; PATHOLOGY; TOXICITY; URINE;

ANIMALS; BERYLLIOSIS; BERYLLIUM; INHALATION EXPOSURE; LUNG; MALE; MICE; MICE, INBRED C3H; PARTICLE SIZE;

EID: 77955348525     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1512     Document Type: Article

References (31)

1. ACGIH. 2009. Beryllium and compounds. In: Documentation of the Threshold Limit Values and Biological Exposure Indices, 7th edn. American Conference of Governmental Industrial Hygienists: Cincinnati, OH; 1-14.
2. Amicosante M, Fontenot AP. 2006. T cell recognition in chronic beryllium disease. Clin. Immunol. 121: 134-143.
3. Apostoli P, Schaller KH. 2001. Urinary beryllium-a suitable tool for assessing occupational and environmental beryllium exposure. Int. Arch. Occup. Environ. Health 74: 162-166.
4. Agency for Toxic Substances and Disease Registry. 1988. Toxicological Profile for Beryllium. Prepared by Syracuse Research Corporation, Atlanta, GA, under contract 68-C8-0004. US Public Health Service. ATSDR/TP-88/09.
5. Agency for Toxic Substances and Disease Registry. 2002. Toxicological Profile for Beryllium. Prepared by Syracuse Research Corporation (MO-015745), Atlanta, GA. Microfiche: PB2003-100135. Available from: http://www.atsdr.cdc. gov/toxprofiles/.
6. Cummings KJ, Stefaniak AB, Virji MA, Kreiss K. 2009. A reconsideration of acute beryllium disease. Environ. Health Perspect. 117(8): 1250-1256.
7. Finch GL, Mewhinney JA, Eidson AF, Hoover MD, Rothenberg, SJ. 1988. In vitro dissolution characteristics of beryllium oxide and beryllium metal aerosols. J. Aerosol Sci. 19(3): 333-342.
8. Finch GL, Mewhinney JA, Hoover MD, Eidson AF, Haley PJ, Bice DE. 1990. Clearance, translocation, and excretion of beryllium following acute inhalation of beryllium oxide by beagle dogs. Fund. Appl. Toxicol. 15(2): 231-241.
9. Fontenot AP, Maier LA, Canavera SJ, Hendry-Hofer TB, Boguniewicz M, Barker EA, Newman LS, Kotzin BL. 2002. Beryllium skin patch testing to analyze T cell stimulation and granulomatous inflammation in the lung. J. Immunol. 168: 3627-3634.
10. Gazette Officielle du Québec. 2006. Réglement modifiant le Règlement sur la santé et la sécurité du travail, 20 december 2006, Partie 2 138(51): 5793-5799.
11. Henneberger PK, Cumro D, Deubner DD, Kent MS, MaCawley M, Kreiss K. 2001. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Int. Arch. Occup. Environ. Health 74: 167-176.
12. Horng CJ, Horng PH, Lin SC, Tsai JL, Lin SR, Tzeng C.C. 2002. Determination of urinary beryllium, arsenic, and selenium in steel production workers. Biol. Trace Elem. Res. 88: 235-246.
13. INRS. 2006. Béryllium et composes minéraux. Fiche toxicologique no. 92. Institut national de recherche et de sé curité: Paris.
14. IRIS. 1998. Toxicological Review of Beryllium and Compounds. US Environmental Protection Agency: Washington, DC. Microfiche: PB98-151756, EPA/635/R-98/008.
15. Kent MS, Robins TG, Madl AK. 2001. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility. Appl. Occup. Environ. Hyg. 16(5): 539-558.
16. Kolanz ME. 2001. Introduction to beryllium: uses, regulatory history and disease. Appl. Occup. Environ. Hyg. 16(5): 559-567.
17. Krachler M, Radner H, Irgolic KJ. 1996. Microwave digestion methods for the determination of trace elements in brain and liver samples by inductively coupled plasma mass spectrometry. Fresenius J. Anal. Chem. 355: 120-128.
18. Kreiss K, Day GA, Schuler CR. 2007. Beryllium: a modern industrial hazard. Annu. Rev. Pub. Health 28: 259-277.
19. Kriebel D, Sprince NL, Eisen EA, Greaves IA, Feldman HA, Greene RE. 1988. Beryllium exposure and pulmonary function: a cross sectional study of beryllium workers. Br. J. Ind. Med. 45(3): 167-173.
20. Nikula KJ, Swafford DS, Hoover MD, Tohulka MD, Finch GL. 1997. Chronic Granulomatous pneumonia and lymphocyte responses induced by inhaled beryllium metal in A/J and C3H/HeJ mice. Toxicol. Pathol. 25: 2-12.
21. Paschal DC, Ting BG, Morrow JC. 1998. Trace metals in urine of United States residents: reference range concentrations. Environ. Res. 76(1): 53-59.
22. Raabe OG, Al-Bayati MA, Teague SV, Rasolt A. 1988. Regional deposition of inhaled monodisperse coarse and fine aerosol particles in small laboratory animals. Ann. Occup. Hyg. 32(suppl. 1): 53-63.
23. Reeves AL. 1986. Beryilium. In: Friberg L, Nordberg GT, Vouk VB, (eds.) Handbook on the toxicology of metals. Second edition. Volume II: Specific metals. New York, NY: Elsevier Science Publishers, 95-116.
24. Rhoads K, Sanders CL. 1985. Lung clearance, translocation, and acute toxicity of arsenic, beryllium, cadmium, cobalt, lead, selenium, vanadium, and ytterbium oxides following deposition in rat lung. Environ. Res. 36(2): 359-378.
25. Salehi F, Zayed J, Audusseau S, Muller C, Truchon G, Plamondon P, L'Espérance G, Chevalier G, Mazer B. 2009. Immunological responses in C3H/HeJ mice following inhalation exposure to different sizes of Beryllium metal particles. J. Appl. Toxicol. 29: 61-68.
26. Sanders CL, Cannon WC, Powers GJ, Adee RR, Meier DM. 1975. Toxicology of high-fired beryllium oxide inhaled by rodents. II. Metabolism and early effects. Arch. Environ. Health 30(11): 546-551.
27. Sawyer RT, Maier LA, Kittle LA, Newman LS. 2002. Chronic Beryllium disease: a model interaction between innate and acquired immunity. Int. Immunopharmacol. 2: 249-261.
28. Stefaniak AB, Day GA, Hoover MD, Breysse PN, Scripsick RC. 2006. Differences in dissolution behavior in a phagolysosomal stimulant fluid for single-constituent and multi-constituent materials associated with beryllium sensitization and chronic beryllium disease. Toxicol. in Vitro 20(1): 82-95.
29. Stefaniak AB, Hoover MD, Dickerson RM, Day GA, Breysse PN, Scripsick RC. 2007. Differences in estimates of size distribution of beryllium powder materials using phase contrast microscopy, scanning electron microscopy, and liquid suspension counter techniques. Part. Fiber Toxicol. 4: 3.
30. Stiefel T, Schulze K, Zorn H. 1980. Toxicokinetic and toxicodynamic studies of beryllium. Arch. Toxicol. 45: 81-92.
31. Zorn H, Stiefel T, Porcher H. 1986. Clinical and analytical follow-up of 25 persons exposed accidently to beryllium. Toxicol. Environ. Chem. 2: 163-171.